BCYC
Price
$7.39
Change
-$0.10 (-1.34%)
Updated
Apr 17 closing price
Capitalization
511.41M
12 days until earnings call
MRKR
Price
$1.15
Change
+$0.07 (+6.48%)
Updated
Apr 17 closing price
Capitalization
12.32M
Ad is loading...

BCYC vs MRKR

Header iconBCYC vs MRKR Comparison
Open Charts BCYC vs MRKRBanner chart's image
Bicycle Therapeutics
Price$7.39
Change-$0.10 (-1.34%)
Volume$144.65K
Capitalization511.41M
Marker Therapeutics
Price$1.15
Change+$0.07 (+6.48%)
Volume$34.58K
Capitalization12.32M
BCYC vs MRKR Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. MRKR commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and MRKR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (BCYC: $7.39 vs. MRKR: $1.15)
Brand notoriety: BCYC and MRKR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 42% vs. MRKR: 25%
Market capitalization -- BCYC: $511.41M vs. MRKR: $12.32M
BCYC [@Biotechnology] is valued at $511.41M. MRKR’s [@Biotechnology] market capitalization is $12.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileMRKR’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • MRKR’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCYC and MRKR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while MRKR’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 3 bearish.
  • MRKR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both BCYC and MRKR are a good buy in the short-term.

Price Growth

BCYC (@Biotechnology) experienced а +13.17% price change this week, while MRKR (@Biotechnology) price change was +11.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

BCYC is expected to report earnings on Jul 31, 2025.

MRKR is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($511M) has a higher market cap than MRKR($12.3M). BCYC YTD gains are higher at: -47.214 vs. MRKR (-63.023). MRKR has higher annual earnings (EBITDA): -10.19M vs. BCYC (-164.89M). BCYC has more cash in the bank: 880M vs. MRKR (9M). MRKR has less debt than BCYC: MRKR (0) vs BCYC (9.49M). BCYC has higher revenues than MRKR: BCYC (35.3M) vs MRKR (0).
BCYCMRKRBCYC / MRKR
Capitalization511M12.3M4,154%
EBITDA-164.89M-10.19M1,617%
Gain YTD-47.214-63.02375%
P/E RatioN/AN/A-
Revenue35.3M0-
Total Cash880M9M9,778%
Total Debt9.49M0-
FUNDAMENTALS RATINGS
BCYC vs MRKR: Fundamental Ratings
BCYC
MRKR
OUTLOOK RATING
1..100
2534
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
9493
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRKR's Valuation (17) in the Other Consumer Services industry is in the same range as BCYC (21) in the null industry. This means that MRKR’s stock grew similarly to BCYC’s over the last 12 months.

MRKR's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as BCYC (100) in the null industry. This means that MRKR’s stock grew similarly to BCYC’s over the last 12 months.

BCYC's SMR Rating (94) in the null industry is in the same range as MRKR (98) in the Other Consumer Services industry. This means that BCYC’s stock grew similarly to MRKR’s over the last 12 months.

MRKR's Price Growth Rating (93) in the Other Consumer Services industry is in the same range as BCYC (94) in the null industry. This means that MRKR’s stock grew similarly to BCYC’s over the last 12 months.

MRKR's P/E Growth Rating (100) in the Other Consumer Services industry is in the same range as BCYC (100) in the null industry. This means that MRKR’s stock grew similarly to BCYC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCYCMRKR
RSI
ODDS (%)
Bullish Trend 3 days ago
76%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with INO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-1.34%
INO - BCYC
51%
Loosely correlated
+1.16%
XNCR - BCYC
49%
Loosely correlated
+1.89%
RPTX - BCYC
48%
Loosely correlated
+4.35%
RLAY - BCYC
47%
Loosely correlated
+3.07%
RCKT - BCYC
41%
Loosely correlated
+2.93%
More

MRKR and

Correlation & Price change

A.I.dvisor tells us that MRKR and RCKT have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRKR and RCKT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRKR
1D Price
Change %
MRKR100%
+6.48%
RCKT - MRKR
30%
Poorly correlated
+2.93%
CGON - MRKR
28%
Poorly correlated
+2.08%
BCYC - MRKR
28%
Poorly correlated
-1.34%
IMVT - MRKR
28%
Poorly correlated
+2.09%
INZY - MRKR
28%
Poorly correlated
-4.40%
More